Patent Assignment
Reel/Frame 040150/0230
Purchase Agreement
Recorded: 2016-09-26
Pages: 29
Assignor
NEW EARTHSHELL CORP
Executed: 2013-03-13
Assignee
WILHELM, MICHAEL
14362 NORTH FRANK LLOYD WRIGHT BLVD, STE 1000, SCOTTSDALE, ARIZONA, 85260
Covered Properties
(60)
Substance P Treatment for Immunostimulation
Patent:
5,945,508 →
Application:
08/829,445 →
Substance P Treatment for Immunostimulation
Patent:
5,998,376 →
Application:
09/028,003 →
Apparatus and Method for Testing Magnetic Disk Drive Components
Patent:
6,099,362 →
Application:
09/078,003 →
Packaging material and method and device for producing the same
Application:
10/339,734 →
Publication:
US 2004/0108243
Stimulation of hair regrowth
Application:
10/539,734 →
Publication:
US 2006/0153789
Acute respiratory syndromes
Application:
10/553,232 →
Publication:
US 2007/0155667
Amelioration of effects of cigarette smoke
Application:
10/645,839 →
Publication:
US 2007/0207123
Inducing And Maintaining Hair Color
Application:
11/587,594 →
Publication:
US 2008/0193403
Anti-Aging Effects Of Substance P
Application:
11/587,595 →
Publication:
US 2008/0167248
Method to Promote Wound Healing
Application:
11/666,474 →
Publication:
US 2008/0318869
Agent to Remove Paint, Lacquer, Glue, Plastic or Similar from Objects and the Use of It
Treatment of Skin Diseases
Application:
11/795,044 →
Publication:
US 2008/0194487
Compositions and Methods for Producing Fermentation Products and Residuals
Application:
11/795,659 →
Publication:
US 2009/0291469
Treatment of asthma
Application:
11/887,105 →
Publication:
US 2009/0286744
Methods of Treating Blood Cell Depletion
Application:
12/179,409 →
Publication:
US 2009/0156504
Method of Using Substance P Analogs for Treatment Amelioration of Myelodysplastic Syndrome
Methods for Stimulating Fibroblast Proliferation Using Substance P Analogs
Application:
12/179,418 →
Publication:
US 2009/0099092
Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance P or an analog thereof
Application:
12/220,403 →
Publication:
US 2009/0028834
Method to Reduce the Risk and/or Severity of Anthrax Infection
Application:
12/282,471 →
Publication:
US 2009/0137492
Method to Treat Blood Cell Depletion
Application:
12/301,426 →
Publication:
US 2010/0062986
Prophylactic and Therapeutic Treatment of Avian Influenza Infections in Animals
Application:
12/376,650 →
Acute respiratory distress syndrome
Application:
60/462,316 →
Acute respiratory syndromes
Application:
60/465,266 →
Anti-aging effects of substance P
Application:
60/565,021 →
Method to promote wound healing
Application:
60/622,015 →
Prevention of respiratory infections in fowl
Application:
60/641,153 →
Treatment of skin diseases
Application:
60/642,996 →
Treatment of asthma
Application:
60/667,062 →
Method to reduce the risk and/or severity of anthrax infection
Application:
60/780,825 →
Method to reduce the risk and/or severity of anthrax infection
Application:
60/781,367 →
Method to treat blood cell depletion
Application:
60/809,391 →
Method to Reduce the Risk and/or Severity of Anthrax Infection
Application:
60/828,723 →
Prophylactic and Therapeutic Treatment of Mammals for Avian Influenza Infections
Application:
60/828,728 →
Prophylactic and therapeutic treatment of mammals for avian influenza infections
Application:
60/837,635 →
Substance P as an Adjuvant
Application:
60/885,562 →
Prophylactic and therapeutic treatment of mammals for avian influenza infections
Application:
60/899,004 →
Method to reduce the risk and/or severity of anthrax infection
Application:
60/899,035 →
Substance P as an Adjuvant
Application:
60/915,358 →
Prophylactic and Therapeutic Treatment of Mammals for Avian Influenza Virus Infections
Application:
60/915,373 →
Method to Treat Blood Cell Depletion, In Conditions Such As MDS
Application:
60/952,394 →
Method to Stimulate Blood Cells Regeneration Following Non-Lethal Radiation Exposure
Application:
60/952,691 →
Substance P and Analogs Thereof as a Vaccine Adjuvant
Application:
60/955,712 →
Swivel squeegee 360
Application:
60/965,560 →
Methods of using substance P and analogs for ameliorating adverse effects of drugs
Application:
60/965,580 →
Use of substance P analogs as PARP inhibitors
Application:
60/966,948 →
Methods of Stimulating or Promoting Fibroblast Proliferation with Substance P or an Analog Thereof
Application:
60/979,769 →
Methods for Stimulating the Proliferation and/or Differentiation of Stem Cells with Substance P, or an Analog Thereof
Application:
60/983,012 →
Methods of using Substance P and analogs thereof to promote cell differentiation
Application:
60/997,314 →
Methods and Compositions for Improving the Texture or Appearance of Skin with Substance P, or an Analog Thereof
Application:
61/016,245 →
Methods of Ex Vivo Expansion of Bone Marrow Cells Using Substance P Analogs
Application:
61/024,354 →
Compositions and Methods for Improving the Texture or Appearance of Human Skin with Substance P Analogs
Application:
61/028,774 →
Methods of Using Substance P Analogs for Stem Cell Growth
Application:
61/038,871 →
Methods of Using Substance P Analogs for Stem Cell Growth
Application:
61/039,686 →
Method of Using Substance P Analogs in Radiation Oncology
Application:
61/039,860 →
Methods of Using Substance P and Analogs for Ameliorating Drug Induced Blood Dyscrasias
Application:
61/039,866 →
Method of Using Substance P Analogs for Amelioration of Myelodysplastic Syndrome
Application:
61/039,867 →
Substance P and Analogs Thereof as a Cancer Immunogenic Composition Adjuvant
Application:
61/045,856 →
Methods and Compositions for Stimulation of Fibroblast Proliferation with Substance P Analogs
Application:
61/047,709 →
Methods of Treating Inflammatory and Fibrotic Lung Diseases with Substance P Analogs
Application:
61/252,059 →
Substance P and Analogs Thereof as Adjuvant Therapy for Adoptive Cellular Immunotherapy
Application:
61/286,709 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Dec 18, 2013
From: GEVO, INC. (AS GRANTOR)
To: TRIPLEPOINT CAPITAL LLC (AS GRANTEE)
Reel/Frame 031847/0342 →
Release of Security Interest
Jan 23, 2015
From: WB GEVO, LTD., AS SUCCESSOR IN INTEREST TO WHITEBOX ADVISORS LLC, AS ADMINISTRATIVE AGENT
To: GEVO, INC.; GEVO DEVELOPMENT, LLC; AGRI-ENERGY, LLC
Reel/Frame 034806/0926 →
Release of Security Interest
Oct 4, 2016
From: TRIPLEPOINT CAPITAL LLC
To: GEVO, INC.
Reel/Frame 040219/0177 →
Release of Security Interest
Jun 21, 2017
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL TRUSTEE
To: GEVO, INC.; GEVO DEVELOPMENT, LLC; AGRI-ENERGY, LLC
Reel/Frame 042940/0081 →
Assignment of Assignor's Interest
Sep 19, 2019
From: WESTERN DIGITAL (FREMONT), LLC
To: WESTERN DIGITAL TECHNOLOGIES, INC.
Reel/Frame 050450/0582 →